Navigation Links
Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting
Date:2/26/2009

ell transplant. No unexpected adverse events have been seen. Toxicities were manageable with supportive care and/or dose reductions as required.

Best response (MR or better) and stable disease (no progression for 3 months) to either perifosine + bortezomib (+/-dexamethasone) for patients previously relapsed from or refractory to prior bortezomib treatment was as follows:

    Evaluable Patients         CR        PR        MR       ORR     SD > 3 mos
    Bortezomib Relapsed
     (n=20)                  2   10%   6   30%   3   15%  11   55%   9   45%
    Bortezomib Refractory
     (n=53)                  1    2%   6   11%  10   19%  17   32%  24   45%
    All Evaluable Patients
     (n=73)                  3    4%  12   16%  13   18%  28   38%  33   45%

Patients who had previously relapsed on a bortezomib-based treatment had a median time to progression (TTP) of 8.5 months. The median TTP for all 73 evaluable study patients (both bortezomib relapsed and refractory) was 6.4 months. As of the report, 16 patients remain on active treatment.

Commenting on the data, Dr. Paul Richardson stated "Perifosine in combination with bortezomib and dexamethasone continues to demonstrate an impressive response rate and time to progression in a heavily pre-treated patient population, with 83% of evaluable patients achieving stable disease or better. Particularly noteworthy is the benefit observed in patients who relapsed on prior bortezomib-based therapy, as reflected by an 8.5 month median time to progression in our study. We continue to be encouraged by the data and look forward to evaluating this combination in a randomized phase 3 trial."

Michael S. Weiss, Chairman and CEO of Keryx Biopharmaceuticals, remarked, "We believe these data confirm the activity of perifosine both in patients who have relapsed following bortezomib therapy and in those patients who were refractory to bort
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
2. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
3. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
4. Keryx Biopharmaceuticals Completes SUN-MICRO Phase 3 Pivotal Trial
5. Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint
6. Keryx Biopharmaceuticals Announces Termination of SUN-MACRO Phase 4 Trial
7. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
8. Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology
9. Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology
10. Inspiration Biopharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of IB1001 for the Treatment of Hemophilia B
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... , May 01, 2015 Research and Markets ... of the "US ACO IT Spending Outlook 2018" ... expected that number of lives covered by ACO would ... In this report, the ACO IT spending has been ... spending on software and spending on services. Our research ...
(Date:5/1/2015)... Calif. , May 1, 2015  Thoratec Corporation (NASDAQ: ... therapies to save, support and restore failing hearts, announced today ... newly created role of President, International. This new ... Thoratec commercial operations outside of North America ... , and Latin America , and ...
(Date:5/1/2015)... 2015  CytRx Corporation (CYTR), a biopharmaceutical research ... financial results for the three months ended March ... accomplishments and upcoming milestones for its clinical development ... the early months of 2015, including the announcement ... aldoxorubicin in patients with soft tissue sarcoma, and ...
Breaking Medicine Technology:United States ACO IT Spending Outlook 2014-2018 2Thoratec Announces Addition To Senior Management Team 2Thoratec Announces Addition To Senior Management Team 3CytRx Reports First Quarter 2015 Financial Results 2CytRx Reports First Quarter 2015 Financial Results 3CytRx Reports First Quarter 2015 Financial Results 4CytRx Reports First Quarter 2015 Financial Results 5CytRx Reports First Quarter 2015 Financial Results 6CytRx Reports First Quarter 2015 Financial Results 7CytRx Reports First Quarter 2015 Financial Results 8CytRx Reports First Quarter 2015 Financial Results 9CytRx Reports First Quarter 2015 Financial Results 10CytRx Reports First Quarter 2015 Financial Results 11
... SAN DIEGO, Dec. 12, 2011  Daiichi Sankyo Company, Limited ... pooled analysis showing that edoxaban, a direct oral once-daily ... venous thromboembolism (VTE) following total knee or hip arthroplasty, ... lower incidence of a composite of deep vein thrombosis ...
... Partnership (SRP) Inc. today announced the availability of ... Third Party Administrators (TPAs), brokers, and other users to ... software tools and the need for expensive outsourcing, SRP,s ... affordable licensing rates with no initial subscription fees. ...
Cached Medicine Technology:Edoxaban Significantly Reduces Risk of Venous Thromboembolism by Half Compared to Enoxaparin in Japanese and Taiwanese Patients Following Knee or Hip Arthroplasty Surgery 2Edoxaban Significantly Reduces Risk of Venous Thromboembolism by Half Compared to Enoxaparin in Japanese and Taiwanese Patients Following Knee or Hip Arthroplasty Surgery 3Edoxaban Significantly Reduces Risk of Venous Thromboembolism by Half Compared to Enoxaparin in Japanese and Taiwanese Patients Following Knee or Hip Arthroplasty Surgery 4Edoxaban Significantly Reduces Risk of Venous Thromboembolism by Half Compared to Enoxaparin in Japanese and Taiwanese Patients Following Knee or Hip Arthroplasty Surgery 5SRP Announces Plan Doc Builder for TPAs and Brokers of Healthcare Plans 2
(Date:5/3/2015)... 03, 2015 Barbara Crone has joined Women’s ... well being of the men, women and families who seek her ... providing care for families in the home. , ... began wondering if I could complete their care with the delivery ... with my mentor Nurse Midwife, I knew it was time for ...
(Date:5/3/2015)... May 03, 2015 Indiana Fiber Network, ... announces Bank Computer Services, Inc (BCS) has selected IFN ... President states, “The technology, service, and working relationship with ... is the local feel you get with IFN. ... company; IFN makes local decisions and operates as a ...
(Date:5/3/2015)... 03, 2015 It is not too late to ... Walk in Memory of Lissa Anne Been in Arnold, Missouri ... great family-friendly event to honor her loving memory. It has benefited ... , Just having turned 37, Lissa suffered a brain aneurysm ... August 24, 2012. This event is designed to serve as a ...
(Date:5/2/2015)... ActOn ” was featured on NewsWatch as part of its ... coolest applications on the market for iOS, Android, and Windows. ... the app review and shared with viewers how this app ... difference. , In this material world, almost everything is about ... which is why those things should be prioritized above others. ...
(Date:5/2/2015)... 2015 On Tuesday April 7th, the ... gathered to celebrate improvements in patient care. In 2014 ... (RVHP), had zero acquired ventilator associated infections, zero central ... ELCH was also recently named a Top Performer by ... ELCH credited the teamwork of staff from all departments ...
Breaking Medicine News(10 mins):Health News:Women's Excellence In Midwifery Welcomes Barbara Crone 2Health News:Bank Computer Services, Inc Selects Indiana Fiber Network, LLC as Fiber Transport Provider 2Health News:Bank Computer Services, Inc Selects Indiana Fiber Network, LLC as Fiber Transport Provider 3Health News:Renowned Brain Aneurysm Foundation to Benefit from Arnold, Missouri’s 3rd Annual Brain Aneurysm Walk in Memory of Lissa Anne Been 2Health News:An Application to Help People Make a Difference Was Featured on NewsWatch Television 2Health News:East Liverpool City Hospital Celebrates Patient Care Improvements 2
... , LONDON, ... and just a few small changes can give big results. But ... us, and the,right ways to improve our health. , ... 25 health-boosting tips,which we believe to be pretty much incontrovertible! Doing ...
... radiation oncologists use advanced imaging techniques such as positron emission ... (4DCT) for target delineation (to locate the tumor and other ... in the December issue of the Journal of the ... ). In defining the target, the radiation oncologist draws ...
... at the University of Miami School of Medicine ... liver transplants for nonalcoholic steatohepatitis (NASH) versus alcoholic ... differences in post-transplant survival rates between the NASH ... the December issue of Liver Transplantation , ...
... University School of Medicine (BUSM) and the Boston ... of proteins whose activation allows them to distinguish ... percent accuracy. In addition, the BU researchers have ... data and specifically identify key biological pathways (molecular ...
... , ... gatherings where food is served are all part of the holiday ... you or others ill. , (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) , Typical ... can start anywhere from hours to days after contaminated food or ...
... , NEW YORK, Nov. 24 As year-end approaches, ... save taxes this year and next. To help you take advantage ... at Thomson Reuters, highlights the following key year-end planning considerations for ... . Many employees take advantage of the annual opportunity ...
Cached Medicine News:Health News:realbuzz.com - Top 25 Ways to Improve Your Health & get a Better Sex Life! 2Health News:New data emerges on liver transplant survival rates 2Health News:New data emerges on liver transplant survival rates 3Health News:Researchers identify proteins in lung cancer cells that may provide potential drug targets 2Health News:FDA Consumer Health Information: Food Safety Tips for Healthy Holidays 2Health News:The Right Tax Moves for Employees to Make Before Year-End 2Health News:The Right Tax Moves for Employees to Make Before Year-End 3Health News:The Right Tax Moves for Employees to Make Before Year-End 4